BRIEF published on 12/19/2025 at 09:19, 8 months 24 days ago Bittium Oyj décroche des contrats de défense et renforce sa position sur le marché. Marché Européen Contrats De Défense Communications Tactiques Bittium Oyj Technologie SDR
BRIEF published on 12/19/2025 at 09:19, 8 months 24 days ago Bittium Oyj Secures Defense Contracts, Enhances Market Position European Market Defense Contracts Tactical Communications Bittium Oyj SDR Technology
PRESS RELEASE published on 12/19/2025 at 09:14, 8 months 24 days ago Original-Research: Bittium Oyj (von NuWays AG): BUY Bittium Oyj receives significant defense-related orders from Finnish and Austrian defense forces, signaling continued growth in the Defense & Security segment with a new target price of EUR 26.50 Security Target Price Orders Defense Bittium Oyj
BRIEF published on 11/19/2025 at 09:05, 9 months 23 days ago Bittium Oyj : Un spécialiste en radio militaire garde le moral Bittium Oyj Technologie Radio Militaire Modernisation De La Bundeswehr Défis D-LBO Intégration Militaire Européenne
BRIEF published on 11/19/2025 at 09:05, 9 months 23 days ago Bittium Oyj: Military-Grade Radio Specialist Maintains Positive Outlook Bittium Oyj Military Radio Technology Bundeswehr Modernization D-LBO Challenges European Military Integration
PRESS RELEASE published on 11/19/2025 at 09:00, 9 months 23 days ago Original-Research: Bittium Oyj (von NuWays AG): Buy Research update by NuWays AG on Bittium Oyj's military-grade radio technology expertise and contrast with R&S's Bundeswehr project issues. Potential involvement in European defense projects NuWays AG Bittium Oyj Military-grade Radios European Defense Projects Rhoede & Schwartz
BRIEF published on 11/06/2025 at 09:06, 10 months 6 days ago Bittium Oyj: A Strategic Transformation in Secure Communications Medical Technology European Expansion Secure Communications Bittium Oyj Defense & Security
BRIEF published on 11/06/2025 at 09:06, 10 months 6 days ago Bittium Oyj : Une transformation stratégique dans les communications sécurisées Expansion Européenne Technologie Médicale Communications Sécurisées Défense Et Sécurité Bittium Oyj
PRESS RELEASE published on 11/06/2025 at 09:01, 10 months 6 days ago Original-Research: Bittium Oyj (von NuWays AG): BUY NuWays AG initiates a BUY recommendation for Bittium Oyj, foreseeing growth in defense & medical technology markets. Strategic partnerships and technological advancements drive transformation Medical Technology Buy Recommendation NuWays AG Defense Technology Bittium Oyj
Published on 09/12/2026 at 02:35, 11 hours 16 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 51 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 46 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 26 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 51 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 21 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 36 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 41 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 6 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 36 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
